Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 24 | 2024 | 4849 | 1.980 |
Why?
|
Hydatidiform Mole | 4 | 2021 | 255 | 1.650 |
Why?
|
Uterine Neoplasms | 6 | 2021 | 1420 | 1.400 |
Why?
|
Neoplasms, Glandular and Epithelial | 6 | 2018 | 487 | 0.950 |
Why?
|
Fallopian Tube Neoplasms | 5 | 2020 | 328 | 0.810 |
Why?
|
Lymph Node Excision | 3 | 2017 | 1269 | 0.720 |
Why?
|
Carcinoma, Endometrioid | 2 | 2021 | 276 | 0.660 |
Why?
|
Ostomy | 1 | 2019 | 33 | 0.650 |
Why?
|
Ovariectomy | 2 | 2018 | 613 | 0.640 |
Why?
|
Platinum Compounds | 1 | 2019 | 95 | 0.630 |
Why?
|
Salpingectomy | 1 | 2018 | 44 | 0.610 |
Why?
|
Ovarian Diseases | 1 | 2019 | 136 | 0.590 |
Why?
|
Abscess | 2 | 2019 | 606 | 0.590 |
Why?
|
Maternal Age | 3 | 2016 | 809 | 0.550 |
Why?
|
Neoplasm Staging | 20 | 2024 | 11116 | 0.520 |
Why?
|
Endometrial Neoplasms | 3 | 2022 | 1365 | 0.510 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2020 | 2020 | 0.480 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2016 | 217 | 0.470 |
Why?
|
Colectomy | 1 | 2019 | 686 | 0.440 |
Why?
|
BRCA2 Protein | 1 | 2018 | 797 | 0.430 |
Why?
|
Papillomaviridae | 1 | 2019 | 1117 | 0.430 |
Why?
|
Ambulatory Care Facilities | 1 | 2019 | 934 | 0.420 |
Why?
|
Papillomavirus Vaccines | 1 | 2019 | 496 | 0.420 |
Why?
|
Chemotherapy, Adjuvant | 10 | 2023 | 3514 | 0.420 |
Why?
|
Neoadjuvant Therapy | 8 | 2023 | 2827 | 0.380 |
Why?
|
Peritoneal Neoplasms | 5 | 2023 | 710 | 0.380 |
Why?
|
Hysterectomy | 3 | 2022 | 856 | 0.370 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1852 | 0.360 |
Why?
|
Leiomyosarcoma | 1 | 2014 | 422 | 0.360 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2024 | 473 | 0.330 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.320 |
Why?
|
Reoperation | 1 | 2019 | 4300 | 0.310 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11736 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9277 | 0.310 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 2 | 2021 | 194 | 0.300 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13635 | 0.290 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1611 | 0.280 |
Why?
|
Neoplasm, Residual | 3 | 2021 | 1008 | 0.270 |
Why?
|
Survival Rate | 8 | 2021 | 12719 | 0.240 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2023 | 56 | 0.220 |
Why?
|
Female | 42 | 2024 | 392148 | 0.210 |
Why?
|
Propensity Score | 3 | 2024 | 1911 | 0.210 |
Why?
|
Retrospective Studies | 19 | 2024 | 80566 | 0.200 |
Why?
|
Laparotomy | 3 | 2021 | 456 | 0.200 |
Why?
|
Balloon Occlusion | 1 | 2022 | 125 | 0.190 |
Why?
|
Carcinosarcoma | 1 | 2021 | 106 | 0.180 |
Why?
|
DNA Mismatch Repair | 2 | 2022 | 428 | 0.170 |
Why?
|
Rupture | 1 | 2021 | 443 | 0.170 |
Why?
|
Adult | 26 | 2024 | 220969 | 0.160 |
Why?
|
Chorionic Gonadotropin | 1 | 2021 | 457 | 0.160 |
Why?
|
Gynecologic Surgical Procedures | 3 | 2020 | 284 | 0.160 |
Why?
|
Placenta Accreta | 1 | 2022 | 237 | 0.150 |
Why?
|
Middle Aged | 24 | 2024 | 220584 | 0.150 |
Why?
|
Aged | 22 | 2024 | 169042 | 0.150 |
Why?
|
Humans | 43 | 2024 | 760617 | 0.150 |
Why?
|
Aged, 80 and over | 13 | 2021 | 58894 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 263 | 0.140 |
Why?
|
Ascites | 1 | 2019 | 338 | 0.140 |
Why?
|
Ovary | 1 | 2021 | 959 | 0.140 |
Why?
|
Gravidity | 1 | 2016 | 50 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2021 | 6807 | 0.130 |
Why?
|
Laparoscopy | 3 | 2020 | 2030 | 0.130 |
Why?
|
Pregnancy | 6 | 2022 | 29868 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6474 | 0.120 |
Why?
|
Cellulose, Oxidized | 1 | 2014 | 12 | 0.120 |
Why?
|
Intraoperative Complications | 1 | 2021 | 1161 | 0.120 |
Why?
|
Behavior Therapy | 1 | 2019 | 877 | 0.110 |
Why?
|
Young Adult | 7 | 2020 | 59179 | 0.110 |
Why?
|
Drainage | 1 | 2019 | 1156 | 0.110 |
Why?
|
Stromal Cells | 1 | 2019 | 1329 | 0.110 |
Why?
|
Vaginal Diseases | 1 | 2014 | 103 | 0.110 |
Why?
|
Parity | 1 | 2016 | 924 | 0.100 |
Why?
|
Fertility | 1 | 2017 | 769 | 0.100 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 590 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1110 | 0.100 |
Why?
|
Genes, BRCA1 | 1 | 2015 | 753 | 0.100 |
Why?
|
United States | 7 | 2023 | 72272 | 0.090 |
Why?
|
Terminal Care | 2 | 2020 | 1755 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1394 | 0.090 |
Why?
|
Postmenopause | 1 | 2019 | 2511 | 0.090 |
Why?
|
Intestines | 1 | 2019 | 1909 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3593 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2020 | 3742 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3599 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8516 | 0.070 |
Why?
|
Adolescent | 4 | 2020 | 88234 | 0.070 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9172 | 0.070 |
Why?
|
Cause of Death | 1 | 2017 | 3683 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12447 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3592 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3612 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4007 | 0.060 |
Why?
|
Prognosis | 4 | 2019 | 29600 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7995 | 0.060 |
Why?
|
Ribose | 1 | 2022 | 63 | 0.050 |
Why?
|
Diphosphates | 1 | 2022 | 84 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4020 | 0.050 |
Why?
|
Incidence | 2 | 2021 | 21337 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 64568 | 0.050 |
Why?
|
Infusions, Parenteral | 1 | 2021 | 397 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20074 | 0.050 |
Why?
|
Iliac Artery | 1 | 2022 | 343 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6340 | 0.040 |
Why?
|
Phthalazines | 1 | 2022 | 383 | 0.040 |
Why?
|
Electrocoagulation | 1 | 2020 | 152 | 0.040 |
Why?
|
Suction | 1 | 2020 | 266 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 13347 | 0.040 |
Why?
|
Blood Loss, Surgical | 1 | 2022 | 636 | 0.040 |
Why?
|
Risk Factors | 3 | 2021 | 74115 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2024 | 1520 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3268 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1755 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39063 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10199 | 0.030 |
Why?
|
New England | 1 | 2016 | 1051 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 732 | 0.020 |
Why?
|
Cohort Studies | 3 | 2020 | 41457 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18381 | 0.020 |
Why?
|
Neoplasms | 1 | 2021 | 22131 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 7960 | 0.020 |
Why?
|
Hemostatics | 1 | 2014 | 240 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2019 | 1403 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1718 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4910 | 0.020 |
Why?
|
Collagen | 1 | 2019 | 2634 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3599 | 0.020 |
Why?
|
Robotics | 1 | 2016 | 816 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2495 | 0.020 |
Why?
|
Medical Oncology | 1 | 2020 | 2317 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2644 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3567 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2014 | 1265 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5304 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26049 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3868 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3461 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2690 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10073 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13495 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13245 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6418 | 0.010 |
Why?
|
MicroRNAs | 1 | 2019 | 3805 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8542 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3533 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26180 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14591 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18221 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 39913 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12966 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54360 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81368 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20556 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168201 | 0.000 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_